Tetrameric Alpha-Synuclein Isolation Without Detergents
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for preparing tetrameric α-synuclein require detergent additives and harsh conditions like boiling or acid treatments, which can alter protein conformation and complicate downstream analysis, limiting the availability of native, detergent-free tetrameric α-synuclein for biochemical studies.
Innovation Solution
A method involving the transformation of an expression system with a NatB acetylase complex to produce N-terminally acetylated α-synuclein, using gentle cell lysis and ammonium sulfate precipitation, followed by anion exchange and size exclusion chromatography, to isolate tetrameric α-synuclein without detergents or harsh treatments.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If detergent additives and harsh treatments (boiling, acid) are used to prepare tetrameric α-synuclein, then the protein can be isolated and purified, but the protein conformation is altered and downstream analysis is complicated
Solution Approach 1:
The patent changes the physical and chemical parameters of the purification process by eliminating detergent additives and harsh treatments (boiling, acid). Instead, it uses mild conditions including physiological pH buffers, controlled temperature (4°C), and gentle centrifugation to maintain the native conformation of tetrameric α-synuclein while achieving isolation and purification.
Solution Approach 2:
The patent introduces an intermediary approach by using a specific buffer system with defined ionic strength and pH conditions that mediates between the need for protein isolation and the need to preserve conformation. The buffer acts as a protective medium that allows tetramer stabilization without requiring harsh detergents or treatments.
2Productivity
If detergent additives are used during lysis and purification, then tetrameric α-synuclein can be recovered, but residual detergent complicates downstream analysis of tetramer dynamics
Solution Approach 1:
The patent extracts and eliminates detergent additives from the purification process. By removing the harmful element (detergent) entirely from the protocol, it achieves tetramer recovery through alternative means (mild lysis, controlled precipitation, gentle chromatography) that do not leave residual contaminants interfering with downstream analysis.
Solution Approach 2:
The patent employs disposable, mild purification conditions that are easily removed or evaporated without leaving persistent residues. The use of volatile buffers and aqueous solutions that can be easily exchanged through dialysis or buffer exchange eliminates the need for persistent detergent stabilization.
3Productivity
If fusion protein platforms are used to generate recombinant tetrameric α-synuclein, then protein production is achieved, but additional amino acid residues remain that are not part of the native sequence
Solution Approach 1:
The patent applies preliminary action by designing the expression system to include protease cleavage sites that allow for the removal of fusion protein tags. The native α-synuclein sequence is prepared in advance with appropriate N-terminal modifications (acetylation) to ensure it is ready for tetramer formation without contaminating fusion residues.
Solution Approach 2:
The patent uses a copying approach where the native human α-synuclein sequence is replicated with high fidelity through optimized expression systems. The expression constructs are designed to produce an accurate copy of the native sequence, including proper N-terminal acetylation, without permanent fusion protein elements that would alter the native structure.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This method provides a reliable, detergent-free source of native tetrameric α-synuclein with high purity and stability, enabling systematic biochemical studies and potential therapeutic developments for Parkinson's disease.
Implementation Method 1
transforming an expression system with an expression vector encoding α-synuclein, wherein the expression system expresses a native NatB acetylase complex or ortholog thereof
Implementation Method 2
performing salt precipitation of the cell lysate, recovering tetrameric N-terminally acetylated α-synuclein by centrifugation
Implementation Method 3
recovering tetrameric N-terminally acetylated α-synuclein by centrifugation
Implementation Method 4
purifying the tetrameric N-terminally acetylated α-synuclein
Implementation Method 5
purifying the tetrameric N-terminally acetylated α-synuclein
Data Source
AI summary
Tetrameric N-terminally acetylated α-synuclein is prepared by transforming an expression system with an expression vector encoding α-synuclein, wherein the expression system expresses a native NatB acetylase complex or ortholog thereof and/or wherein an exogenous NatB acetylase complex or ortholog thereof is co-expressed in the expression system, inducing protein expression in the transformed expression system, lysing cells in the transformed expression system to produce a cell lysate, performing salt precipitation of the cell lysate, recovering tetrameric N-terminally acetylated α-synuclein by centrifugation, and purifying the tetrameric N-terminally acetylated α-synuclein. Compositions comprising the same and methods for identifying compounds that stabilize natively folded tetrameric α-synuclein are also provided.